New frontiers of PDAC screening and treatment with a basic scientist Pilar Acedo

From RAS inhibitors to a KRAS vaccine: new hope in pancreatic cancer in this first part, Eglė talks with Dr Pilar Acedo Nuñez, a senior research fellow and junior principal investigator at UCL. Pilar co-leads the Pereira/Acedo Lab, which works on biomarkers for the early detection of pancreatic cancer and cholangiocarcinoma, and she is a former chair of the UEG Young Talent Group. Further reading - Daraxonrasib or chemotherapy in previously treated metastatic pancreatic cancer - First-in-human trial of mutant KRAS vaccine